T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty

Citation
M. Osada et al., T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty, J INTERF CY, 21(4), 2001, pp. 219-221
Citations number
18
Categorie Soggetti
Immunology
Journal title
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
ISSN journal
10799907 → ACNP
Volume
21
Issue
4
Year of publication
2001
Pages
219 - 221
Database
ISI
SICI code
1079-9907(200104)21:4<219:TLAARA>2.0.ZU;2-F
Abstract
We investigated the relation between the activation of T lymphocytes and th e occurrence of restenosis after percutaneous transluminal coronary angiopl asty (PTCA) in 10 stable angina patients. Recent studies have suggested tha t PTCA causes an inflammatory response, which may affect restenosis after a ngioplasty. Soluble interleukin-2 receptor (sIL-2R) is a useful marker to e valuate the activation of T lymphocytes. sIL-2R was measured before and 2 h after successful PTCA, and 3-month follow-up coronary angiography was done to observe restenosis. Four of 10 patients showed restenosis. The restenos is group of 4 patients had a higher level of sIL-2R after PTCA than the no- restenosis group of 6 patients (495 vs. 274 U/ml, p < 0.01). This study sug gests that sIL-2R may offer prognostic information after elective PTCA and identify a subgroup of patients at high risk for clinical restenosis in a f ew months.